Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib add-on therapy and inflammatory markers in major depression
2009-011990-34Phase 2Completed
- Sponsor
- Department of Psychiatry, LMU Munich
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of celecoxib in major depressive disorder (MDD) (2 arms), sponsored by Department of Psychiatry, LMU Munich. Primary endpoints: Change in inflammatory and metabolic markers and Change in HamD-17 score from baseline to week 6. Started Nov 2010; status: completed.
02
Drugs
celecoxib
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2009-011990-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011990-34.